A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy

by Goemans, N., Mercuri, E., Belousova, E., Komaki, H., Dubrovsky, A., McDonald, C.M., Kraus, J.E., Lourbakos, A., Lin, Z.N., Campion, G., Wang, S.X., Campbell, C., DEMAND III Study Grp
Published 2018